Histogenics Corporation (HSGX) financial statements (2021 and earlier)

Company profile

Business Address 5 GREAT VALLEY PARKWAY
MALVERN, PA 19355
State of Incorp. DE
Fiscal Year End December 31
SIC 2836 - Biological Products, Except Diagnostic Substances (benchmarking)
More info Complete financial analysis Financial benchmarking

Balance sheet (Statement of financial position) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
ASSETS
Current Assets
Cash, cash equivalents, and short-term investments715371659
Cash and cash equivalents715371659
Prepaid expense    1  
Assets held-for-sale, not part of disposal group77     
Other current assets    0  
Other undisclosed current assets1101 11
Total current assets:16233816610
Noncurrent Assets
Property, plant and equipment00 0045
Restricted cash and investments00 0000
Other noncurrent assets10 6100
Total noncurrent assets:11 7155
TOTAL ASSETS:1724315171115
LIABILITIES AND EQUITY
Liabilities
Current Liabilities
Accounts payable and accrued liabilities4711344
Accounts payable2611222
Accrued liabilities2100122
Debt00     
Deferred rent credit    000
Deferred lease income    000
Contract with customer, liability 58
Other liabilities0      
Other undisclosed current liabilities 28 1   
Total current liabilities:535123912
Noncurrent Liabilities
Long-term debt and lease obligation11     
Long-term debt, excluding current maturities11     
Finance lease, liability 0  
Operating lease, liability00  
Liabilities, other than long-term debt0 1111141126
Accounts payable and accrued liabilities  003220
Contract with customer, liability10101053
Deferred rent credit    000
Due to related parties  11133
Other liabilities0      
Other undisclosed noncurrent liabilities   7111
Total noncurrent liabilities:111118151227
Total liabilities:6371220182139
Stockholders' equity
Stockholders' equity attributable to parent, including:11(13)(9)(6)(0)(10)(23)
Common stock1011100
Treasury stock, value(0)      
Additional paid in capital6251220220216206203
Retained earnings (accumulated deficit)51(64)(229)(226)(217)(216)(227)
Other undisclosed stockholders' equity attributable to parent(103)      
Total stockholders' equity:11(13)(9)(6)(0)(10)(23)
TOTAL LIABILITIES AND EQUITY:1724315171115

Income statement (P&L) ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Gross profit:   (1)   
Operating expenses(4)(3)(3)(8)(10)(7)(7)
Other undisclosed operating income   1   
Operating loss:(4)(3)(3)(8)(10)(7)(7)
Nonoperating income (expense)17(20)(0)(1)9184
Other nonoperating income (expense)(0)(1)0(0)(0)(0)(0)
Interest and debt expense(0)(1)     
Income (loss) before gain (loss) on sale of properties:12(24)(3)(9)(1)11(4)
Other undisclosed net income0      
Net income (loss):12(24)(3)(9)(1)11(4)
Other undisclosed net income attributable to parent 1     
Net income (loss) attributable to parent:12(23)(3)(9)(1)11(4)
Other undisclosed net loss available to common stockholders, basic    (0)(0) 
Net income (loss) available to common stockholders, basic:12(23)(3)(9)(1)11(4)
Other undisclosed net loss available to common stockholders, diluted    (8)(18) 
Net income (loss) available to common stockholders, diluted:12(23)(3)(9)(9)(7)(4)

Comprehensive Income ($ in millions)

12/31/2019
Q4
9/30/2019
Q3
6/30/2019
Q2
3/31/2019
Q1
12/31/2018
Q4
9/30/2018
Q3
6/30/2018
Q2
Net income (loss):12(24)(3)(9)(1)11(4)
Comprehensive income (loss):12(24)(3)(9)(1)11(4)
Other undisclosed comprehensive income, net of tax, attributable to parent 1     
Comprehensive income (loss), net of tax, attributable to parent:12(23)(3)(9)(1)11(4)

Statements sources

The financial statements are based on the company's filings with the The U.S. Securities and Exchange Commission (SEC) through the Electronic Data Gathering, Analysis, and Retrieval system (EDGAR). The information is derived from the 10-K and 10-Q reports submitted to the SEC in XBRL (eXtensible Business Reporting Language) format and presented according to the US GAAP Taxonomy. Please review the original filings for a more detailed information.

Login to ReadyRatios

 

Have you forgotten your password?

Are you a new user?

Login As
You can log in if you are registered at one of these services: